Neumoloxía
Servizo
Hospital de Cruces
Barakaldo, EspañaPublicacións en colaboración con investigadores/as de Hospital de Cruces (33)
2024
-
Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients
Allergy: European Journal of Allergy and Clinical Immunology
-
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study
ERJ Open Research, Vol. 10, Núm. 1
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia
2023
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
-
Factors associated with suboptimal response to monoclonal antibodies in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology
-
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma
Journal of Investigational Allergology and Clinical Immunology
2022
-
Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group
Archivos de Bronconeumologia, Vol. 58, Núm. 11, pp. 776-779
-
Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283
-
Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
Chest, Vol. 162, Núm. 4, pp. 768-781
-
Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21
-
Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study
Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674
-
[Translated article] Tuberculosis contacts tracing in Spain: Cost analysis
Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. T448-T450
2021
-
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27
-
Ceramide metabolism and parkinson’s disease—therapeutic targets
Biomolecules, Vol. 11, Núm. 7
-
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis
Scientific Reports, Vol. 11, Núm. 1
-
Tuberculosis contacts tracing in Spain: Cost analysis
Archivos de Bronconeumologia
2020
-
Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
-
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Respiratory Medicine, Vol. 170